X @Bloomberg
Bloomberg·2026-03-09 09:14
The US Food and Drug Administration is easing some requirements for drugmakers developing copycat versions of costly biologic medications https://t.co/JB4m0OLaHL ...
The US Food and Drug Administration is easing some requirements for drugmakers developing copycat versions of costly biologic medications https://t.co/JB4m0OLaHL ...